Telo Genomics Statistics

Total Valuation

Telo Genomics has a market cap or net worth of CAD 11.50 million. The enterprise value is 10.25 million.

Market Cap	11.50M
Enterprise Value	10.25M

Important Dates

The next estimated earnings date is Friday, September 26, 2025.

Earnings Date	Sep 26, 2025
Ex-Dividend Date	n/a

Share Statistics

Telo Genomics has 100.02 million shares outstanding. The number of shares has increased by 16.94% in one year.

Current Share Class	100.02M
Shares Outstanding	100.02M
Shares Change (YoY)	+16.94%
Shares Change (QoQ)	+30.28%
Owned by Insiders (%)	4.02%
Owned by Institutions (%)	n/a
Float	96.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	10.24
P/TBV Ratio	10.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.93
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.31

Financial Position

The company has a current ratio of 4.95

Current Ratio	4.95
Quick Ratio	4.66
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-532.64

Financial Efficiency

Return on equity (ROE) is -303.19% and return on invested capital (ROIC) is -190.75%.

Return on Equity (ROE)	-303.19%
Return on Assets (ROA)	-145.76%
Return on Invested Capital (ROIC)	-190.75%
Return on Capital Employed (ROCE)	-234.06%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.84% in the last 52 weeks. The beta is 0.09, so Telo Genomics's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-37.84%
50-Day Moving Average	0.09
200-Day Moving Average	0.12
Relative Strength Index (RSI)	64.24
Average Volume (20 Days)	41,071

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.63M
Pretax Income	-2.61M
Net Income	-2.61M
EBITDA	-2.61M
EBIT	-2.63M
Earnings Per Share (EPS)	-0.03

Full Income Statement

Balance Sheet

The company has 1.25 million in cash and n/a in debt, giving a net cash position of 1.25 million or 0.01 per share.

Cash & Cash Equivalents	1.25M
Total Debt	n/a
Net Cash	1.25M
Net Cash Per Share	0.01
Equity (Book Value)	1.12M
Book Value Per Share	0.01
Working Capital	1.08M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.37 million and capital expenditures -5,565, giving a free cash flow of -2.38 million.

Operating Cash Flow	-2.37M
Capital Expenditures	-5,565
Free Cash Flow	-2.38M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Telo Genomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.94%
Shareholder Yield	n/a
Earnings Yield	-22.70%
FCF Yield	-20.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 22, 2019. It was a reverse split with a ratio of 0.2.

Last Split Date	Nov 22, 2019
Split Type	Reverse
Split Ratio	0.2

Scores

Altman Z-Score	n/a
Piotroski F-Score	2